Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancerFranziska Haderk, Trever G. Bivona, Ismail M. Meraz et al.|Nature Communications|2024Cited by 95
RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancerOghenekevwe M. Gbenedio, Philippe Depeille|JCI Insight|2019Cited by 23
A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancerFranziska Haderk, Trever G. Bivona, Celia Fernández-Méndez et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 18